• 1. Department of Cardiology, the General Hospital of Shenyang Military, Shenyang, Liaoning 110016, P. R. China;
  • 2. Department of Cardiology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P. R. China;
HAN Yaling, Email: hanyalingnh@163.com
Export PDF Favorites Scan Get Citation

Transcatheter aortic valve replacement (TAVR) developed rapidly since firstly introduced to clinical practice in 2002. In 2015, Experts Consensus for Transeatheter Aortic Valve Replacement (abbreviated as the Consensus) helped TAVR develop normatively and safely in China. This article interpreted the Consensus in combination of new evolutions of TAVR field: first, the indications of TAVR expand from inoperative and high risk patients to the intermediate risk patients; second, although the Consensus recommended pre-dilation with balloon of modest size, the necessity of pre-dilation is under debate; third, the Consensus pointed out main complications of TAVR, and the main strategies to avoid complications are careful pre-procedural analysis and development of new device; fourth, our experts had made outstanding contribution to TAVR in the treatment of patients with bicuspid aortic valve, which still has many problems to be solved urgently.

Citation: HAN Yaling, XU Kai, CHEN Mao. Interpretation of 2015 Experts Consensus for Transcatheter Aortic Valve Replacement. West China Medical Journal, 2018, 33(2): 154-156. doi: 10.7507/1002-0179.201801153 Copy